Items where Author is "Wittig, B. M."
Jump to: Article Number of items: 6. ArticleHolzloehner, P. and Heilmann, K. and Loddenkemper, C. and Zeitz, M. and Gunthert, U. and Wittig, B. M.. (2008) Macrophage deletion of CD44v7 induces tolerance in transfer colitis by induction of FOXP3 positive treg cells. Gastroenterology, Vol. 134, H. 4 , A42-A43. Hoffmann, U. and Heilmann, K. and Hayford, C. and Stallmach, A. and Wahnschaffe, U. and Zeitz, M. and Günthert, U. and Wittig, B. M.. (2007) CD44v7 ligation downregulates the inflammatory immune response in Crohn's disease patients by apoptosis induction in mononuclear cells from the lamina propria. Cell death and differentiation, 14 (8). pp. 1542-1551. Farkas, S. and Hornung, M. and Sattler, C. and Anthuber, M. and Gunthert, U. and Herfarth, H. and Schlitt, H. J. and Geissler, E. K. and Wittig, B. M.. (2005) Short-term treatment with anti-CD44v7 antibody, but not CD44v4, restores the gut mucosa in established chronic dextran sulphate sodium (DSS)-induced colitis in mice. Clinical and experimental immunology, 142 (2). pp. 260-267. Wittig, B. M. and Stallmach, A. and Zeitz, M. and Gunthert, U.. (2002) Functional involvement of CD44 variant 7 in gut immune response. Pathobiology, 70 (3). pp. 184-189. Wittig, B. M. and Johansson, B. and Zöller, M. and Schwärzler, C. and Günthert, U.. (2000) Abrogation of experimental colitis correlates with increased apoptosis in mice deficient for CD44 variant exon 7 (CD44v7). Journal of experimental medicine, Vol. 191, No. 12. pp. 2053-2064. Wittig, B. M. and Gunthert, U. and Zoller, M.. (1998) Blockade of CD44 variant exon V7 prevents experimental colitis. Gastroenterology, Vol. 114, H. 4 , A1115. |
